Axsome Therapeutics, Inc.AXSMNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+53.0%
5Y CAGR+81.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+53.0%/yr
vs +103.1%/yr prior
5Y CAGR
+81.6%/yr
Recent deceleration
Acceleration
-50.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
19.7x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $570.60M | +38.7% |
| 2024 | $411.36M | +27.3% |
| 2023 | $323.12M | +102.9% |
| 2022 | $159.25M | +139.0% |
| 2021 | $66.65M | +130.6% |
| 2020 | $28.90M | +112.5% |
| 2019 | $13.60M | +45.4% |
| 2018 | $9.35M | +29.8% |
| 2017 | $7.21M | +13.6% |
| 2016 | $6.34M | - |